Khalid Almahmoud
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Khalid Almahmoud has a total of 86 co-authors. Here are the top co-authors by number of shared publications:
- Rami Ahmd Namas
Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
9 shared publications - Yoram Vodovotz
Department of Surgery, University of Pittsburgh
8 shared publications - Akram M. Zaaqoq
Department of Anesthesiology, Division of Critical Care, University of Virginia, Charlottesville, VA
7 shared publications Timothy R. Billiar
Department of Surgery, Division of Trauma & Critical Care Surgery, University of Pittsburgh, Pittsburgh, PA, United States of America
7 shared publicationsJason Sperry
Department of Surgery, Division of Trauma & Critical Care Surgery, University of Pittsburgh, Pittsburgh, PA, United States of America
6 shared publicationsOthman Abdul-Malak
Department of Surgery, University of Pittsburgh, Pittsburgh, PA 15213
5 shared publications
Latest Publications
- 4 September 2026
- Published by SAGE Publications in The American Surgeon™
Why 30 mg Twice Daily Fails: Anti-Factor Xa Monitoring and the Persistent Dosing Gap in High-Risk Trauma Patients
Introduction: Contemporary trauma guidelines support higher initial enoxaparin dosing for adult trauma patients, as standard dosing (30 mg twice daily [BID]) frequently fails to achieve target anticoagulant activity. While anti-factor Xa (anti-Xa) monitoring guides dose adjustments, real-world implementation of follow-up monitoring remains variable. This study evaluated anti-Xa target attainment, dose escalation practices, and completion of follow-up monitoring in high-risk trauma patients. Methods: This retrospective cohort study at a Level I trauma center included adult trauma patients (April 2022-October 2023) receiving enoxaparin venous thromboembolism prophylaxis who underwent at least one anti-Xa measurement. Demographics, Injury Severity Score (ISS), dosing changes, and repeat monitoring frequencies were analyzed. This study evaluated real-world clinical practice and was not designed to compare dosing strategies or assess a protocolized intervention. Results: Among 244 patients (median ISS 22; 43% with BMI >40 kg/m 2 ), 80% initially received standard dosing (30 mg BID). Only 42% achieved target prophylactic anti-Xa levels (0.2–<0.5 IU/mL). Of those on standard dosing, 34% required escalation, with the mean adjusted dose approaching 40 mg BID. While 68% of patients who underwent repeat testing after dose escalation successfully achieved target levels, repeat monitoring was completed in only 22% of all adjusted patients. Venous thromboembolism occurred in 5%, and bleeding in 7%. Conclusion: Standard enoxaparin dosing frequently fails high-risk trauma patients, supporting contemporary higher-dose guidelines. However, a critical implementation gap persists; while clinicians recognize subtherapeutic levels and escalate doses, follow-up anti-Xa monitoring is inconsistently performed. Standardized tracking protocols and automated electronic triggers are required to close the loop in anti-Xa pathways.
- 4 September 2026
- Published by SAGE Publications in The American Surgeon™
Why 30 mg Twice Daily Fails: Anti-Factor Xa Monitoring and the Persistent Dosing Gap in High-Risk Trauma Patients
Introduction: Contemporary trauma guidelines support higher initial enoxaparin dosing for adult trauma patients, as standard dosing (30 mg twice daily [BID]) frequently fails to achieve target anticoagulant activity. While anti-factor Xa (anti-Xa) monitoring guides dose adjustments, real-world implementation of follow-up monitoring remains variable. This study evaluated anti-Xa target attainment, dose escalation practices, and completion of follow-up monitoring in high-risk trauma patients. Methods: This retrospective cohort study at a Level I trauma center included adult trauma patients (April 2022-October 2023) receiving enoxaparin venous thromboembolism prophylaxis who underwent at least one anti-Xa measurement. Demographics, Injury Severity Score (ISS), dosing changes, and repeat monitoring frequencies were analyzed. This study evaluated real-world clinical practice and was not designed to compare dosing strategies or assess a protocolized intervention. Results: Among 244 patients (median ISS 22; 43% with BMI >40 kg/m 2 ), 80% initially received standard dosing (30 mg BID). Only 42% achieved target prophylactic anti-Xa levels (0.2–<0.5 IU/mL). Of those on standard dosing, 34% required escalation, with the mean adjusted dose approaching 40 mg BID. While 68% of patients who underwent repeat testing after dose escalation successfully achieved target levels, repeat monitoring was completed in only 22% of all adjusted patients. Venous thromboembolism occurred in 5%, and bleeding in 7%. Conclusion: Standard enoxaparin dosing frequently fails high-risk trauma patients, supporting contemporary higher-dose guidelines. However, a critical implementation gap persists; while clinicians recognize subtherapeutic levels and escalate doses, follow-up anti-Xa monitoring is inconsistently performed. Standardized tracking protocols and automated electronic triggers are required to close the loop in anti-Xa pathways.
- 2 September 2026
- Published by SAGE Publications in The American Surgeon™
Mesenteric Hematoma as a Warning Sign for Missed Bowel Injury
Background: Mesenteric hematoma (MH) after blunt abdominal trauma may obscure underlying bowel injury, creating a diagnostic gray zone. We evaluated whether MH identifies patients at higher risk for delayed bowel injury and worse outcomes, informing risk-stratified observation. Methods: Adult blunt trauma patients (≥18 years) admitted between January 2018 and August 2025 with MH on initial CT imaging of the abdomen and pelvis and no definitive bowel perforation were retrospectively reviewed (n = 56). Patients were matched 1:1 with trauma patients without MH or bowel injury (N-MH, n = 56) by age, sex, injury mechanism, Injury Severity Score (ISS), and abdominal Abbreviated Injury Scale (AIS). Outcomes, imaging findings, and admission lactic acid were analyzed. Conditional logistic regression identified factors associated with missed bowel injury within 24 h. Results: Fifty-six patients with mesenteric hematoma and no definitive CT evidence of bowel perforation were identified. Patients with mesenteric hematoma demonstrated higher admission lactate levels compared with controls. Delayed bowel injury was diagnosed in 7 patients (12.5%) within the first 24 h of hospitalization despite initially inconclusive imaging. Admission lactic acid was independently associated with missed bowel injury (OR 1.10 per mmol/L; 95% CI: 1.01-1.21; P = 0.02). Conclusions: Mesenteric hematoma on CT imaging may identify a subgroup of trauma patients at increased risk for delayed bowel injury. These findings suggest that patients with mesenteric hematoma may benefit from heightened surveillance, including serial clinical examinations, physiologic monitoring, and consideration of repeating imaging during the early post-injury period.
- 2 September 2026
- Published by SAGE Publications in The American Surgeon™
Mesenteric Hematoma as a Warning Sign for Missed Bowel Injury
Background: Mesenteric hematoma (MH) after blunt abdominal trauma may obscure underlying bowel injury, creating a diagnostic gray zone. We evaluated whether MH identifies patients at higher risk for delayed bowel injury and worse outcomes, informing risk-stratified observation. Methods: Adult blunt trauma patients (≥18 years) admitted between January 2018 and August 2025 with MH on initial CT imaging of the abdomen and pelvis and no definitive bowel perforation were retrospectively reviewed (n = 56). Patients were matched 1:1 with trauma patients without MH or bowel injury (N-MH, n = 56) by age, sex, injury mechanism, Injury Severity Score (ISS), and abdominal Abbreviated Injury Scale (AIS). Outcomes, imaging findings, and admission lactic acid were analyzed. Conditional logistic regression identified factors associated with missed bowel injury within 24 h. Results: Fifty-six patients with mesenteric hematoma and no definitive CT evidence of bowel perforation were identified. Patients with mesenteric hematoma demonstrated higher admission lactate levels compared with controls. Delayed bowel injury was diagnosed in 7 patients (12.5%) within the first 24 h of hospitalization despite initially inconclusive imaging. Admission lactic acid was independently associated with missed bowel injury (OR 1.10 per mmol/L; 95% CI: 1.01-1.21; P = 0.02). Conclusions: Mesenteric hematoma on CT imaging may identify a subgroup of trauma patients at increased risk for delayed bowel injury. These findings suggest that patients with mesenteric hematoma may benefit from heightened surveillance, including serial clinical examinations, physiologic monitoring, and consideration of repeating imaging during the early post-injury period.
- 17 September 2025
- Published by Wiley in Transfusion
- Vol. 65 (11) , 2105-2112
Provider uptake of the anemia protocol across different intensive care units over 5 years in urban medical center
Background: Anemia is a common condition among critically ill patients. To address this, patient blood management (PBM) programs have been introduced to enhance anemia treatment while reducing the need for transfusions. This study assesses the implementation and effectiveness of an anemia management protocol across multiple intensive care units (ICUs), with a particular emphasis on its impact within the trauma ICU (TICU). Methods: We retrospectively reviewed ICU patients at AGH from 2016 to 2020. Adult patients (≥18 years) with an admission hemoglobin p < .001). Within the TICU, patients receiving the protocol had fewer daily blood draws ( p = .04), lower transfusion rates ( p = .001), and higher average hemoglobin levels ( p = .03) compared to those not managed with the protocol. Over time, protocol use in the TICU increased from 15% in 2016 to 41% in 2020 ( p < .001), which correlated with reductions in transfusions and blood draws. Conclusion: The adoption of a structured AP was linked to enhanced anemia management, decreased transfusion requirements, and fewer blood draws in ICU patients. The TICU showed the highest rate of protocol adoption and the most notable improvements. These results support the broader implementation of protocol‐driven PBM approaches to optimize outcomes in ICU settings.
- 17 September 2025
- Published by Wiley in Transfusion
- Vol. 65 (11) , 2105-2112
Provider uptake of the anemia protocol across different intensive care units over 5 years in urban medical center
Background: Anemia is a common condition among critically ill patients. To address this, patient blood management (PBM) programs have been introduced to enhance anemia treatment while reducing the need for transfusions. This study assesses the implementation and effectiveness of an anemia management protocol across multiple intensive care units (ICUs), with a particular emphasis on its impact within the trauma ICU (TICU). Methods: We retrospectively reviewed ICU patients at AGH from 2016 to 2020. Adult patients (≥18 years) with an admission hemoglobin p < .001). Within the TICU, patients receiving the protocol had fewer daily blood draws ( p = .04), lower transfusion rates ( p = .001), and higher average hemoglobin levels ( p = .03) compared to those not managed with the protocol. Over time, protocol use in the TICU increased from 15% in 2016 to 41% in 2020 ( p < .001), which correlated with reductions in transfusions and blood draws. Conclusion: The adoption of a structured AP was linked to enhanced anemia management, decreased transfusion requirements, and fewer blood draws in ICU patients. The TICU showed the highest rate of protocol adoption and the most notable improvements. These results support the broader implementation of protocol‐driven PBM approaches to optimize outcomes in ICU settings.
- Open Access
- 4 June 2019
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 14 (6) , e0217577
Computational evidence for an early, amplified systemic inflammation program in polytrauma patients with severe extremity injuries
Extremity and soft tissue injuries contribute significantly to inflammation and adverse in-hospital outcomes for trauma survivors; accordingly, we examined the complex association between clinical outcomes inflammatory responses in this setting using in silico tools. Two stringently propensity-matched, moderately/severely injured (Injury Severity Score > 16) patient sub-cohorts of ~30 patients each were derived retrospectively from a cohort of 472 blunt trauma survivors and segregated based on their degree of extremity injury severity (above or below 3 on the Abbreviated Injury Scale). Serial blood samples were analyzed for 31 plasma inflammatory mediators. In addition to standard statistical analyses, Dynamic Network Analysis (DyNA) and Principal Component Analysis (PCA) were used to model systemic inflammation following trauma. Patients in the severe extremity injury sub-cohort experienced longer intensive care unit length of stay (LOS), total LOS, and days on a mechanical ventilator, with higher Marshall Multiple Organ Dysfunction (MOD) Scores over the first 7 days post-injury as compared to the mild/moderate extremity injury sub-cohort. The higher severity cohort had statistically significant elevated lactate, base deficit, and creatine phosphokinase on first blood draw, along with significant changes in multiple circulating inflammatory mediators. DyNA pointed to a sustained role for type 17 immunity in both sub-cohorts, along with IFN-γ in the severe extremity injury group. DyNA network complexity increased over 7 days post-injury in the severe injury group, while generally decreasing over this same time period in the mild/moderate injury group. PCA suggested a more robust activation of multiple pathways in the severe extremity injury group as compared to the mild/moderate injury group. These studies thus point to the possibility of self-sustaining inflammation following severe extremity injury vs. resolving inflammation following less severe extremity injury.
- 4 June 2019
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 14 (6) , e0217577
Open AccessComputational evidence for an early, amplified systemic inflammation program in polytrauma patients with severe extremity injuries
Extremity and soft tissue injuries contribute significantly to inflammation and adverse in-hospital outcomes for trauma survivors; accordingly, we examined the complex association between clinical outcomes inflammatory responses in this setting using in silico tools. Two stringently propensity-matched, moderately/severely injured (Injury Severity Score > 16) patient sub-cohorts of ~30 patients each were derived retrospectively from a cohort of 472 blunt trauma survivors and segregated based on their degree of extremity injury severity (above or below 3 on the Abbreviated Injury Scale). Serial blood samples were analyzed for 31 plasma inflammatory mediators. In addition to standard statistical analyses, Dynamic Network Analysis (DyNA) and Principal Component Analysis (PCA) were used to model systemic inflammation following trauma. Patients in the severe extremity injury sub-cohort experienced longer intensive care unit length of stay (LOS), total LOS, and days on a mechanical ventilator, with higher Marshall Multiple Organ Dysfunction (MOD) Scores over the first 7 days post-injury as compared to the mild/moderate extremity injury sub-cohort. The higher severity cohort had statistically significant elevated lactate, base deficit, and creatine phosphokinase on first blood draw, along with significant changes in multiple circulating inflammatory mediators. DyNA pointed to a sustained role for type 17 immunity in both sub-cohorts, along with IFN-γ in the severe extremity injury group. DyNA network complexity increased over 7 days post-injury in the severe injury group, while generally decreasing over this same time period in the mild/moderate injury group. PCA suggested a more robust activation of multiple pathways in the severe extremity injury group as compared to the mild/moderate injury group. These studies thus point to the possibility of self-sustaining inflammation following severe extremity injury vs. resolving inflammation following less severe extremity injury.
- 13 January 2017
- Published by Springer Nature in European Journal of Trauma and Emergency Surgery
- Vol. 44 (2) , 155-162
Impact of pelvic fractures on the early clinical outcomes of severely injured trauma patients
Background Pelvic fractures contribute to morbidity and mortality following injury. We sought to study the impact of pelvic fractures on the clinical course and outcomes of trauma patients with a pelvic fracture in comparison to patients with similar injury severity without pelvic fracture to identify potential parameters to track patients’ clinical course post-injury. Methods A cohort of 206 consecutive blunt trauma survivors, studied over a 5-year period in a level I trauma center of which 75 patients (36.4%) had a pelvic fracture, was included in the study. To perform a retrospective cohort study with matched controls, 60 patients of the pelvic fracture group [(PF), 41 males and 19 females; age: 40 ± 17; injury severity score (ISS): 26.6 ± 9.3] were compared to 60 patients without pelvic fracture (non-PF) trauma as controls (41 males and 19 females; age: 40 ± 13; ISS: 26.9 ± 7.7), both with matching age (±5 years), sex, and ISS (±5 points). Results Statistically significant differences were observed in Intensive Care Unit (ICU) length of stay (LOS), total LOS, and Marshall MOD score between PF and non-PF groups, respectively. Acid–base markers such as pH, lactate, LDH, and base deficit were all significantly altered in PF compared to non-PF cohort upon admission. Moreover, our analysis showed significant differences in inflammatory biomarkers (Prolactin, CRP, and IL-6), and clinical parameters (CPK, Hgb, Platelets count, and WBC) over the 7-day clinical course in patients with PF when compared to non-PF cohort. Conclusion In this matched cohort, patients with pelvic fractures exhibited biochemical and physiological alterations upon admission. Furthermore, our results suggest that pelvic fracture affects the clinical outcomes in severely injured patients, independently of injury severity, mechanism of injury, age or gender.
- 13 January 2017
- Published by Springer Nature in European Journal of Trauma and Emergency Surgery
- Vol. 44 (2) , 155-162
Impact of pelvic fractures on the early clinical outcomes of severely injured trauma patients
Background Pelvic fractures contribute to morbidity and mortality following injury. We sought to study the impact of pelvic fractures on the clinical course and outcomes of trauma patients with a pelvic fracture in comparison to patients with similar injury severity without pelvic fracture to identify potential parameters to track patients’ clinical course post-injury. Methods A cohort of 206 consecutive blunt trauma survivors, studied over a 5-year period in a level I trauma center of which 75 patients (36.4%) had a pelvic fracture, was included in the study. To perform a retrospective cohort study with matched controls, 60 patients of the pelvic fracture group [(PF), 41 males and 19 females; age: 40 ± 17; injury severity score (ISS): 26.6 ± 9.3] were compared to 60 patients without pelvic fracture (non-PF) trauma as controls (41 males and 19 females; age: 40 ± 13; ISS: 26.9 ± 7.7), both with matching age (±5 years), sex, and ISS (±5 points). Results Statistically significant differences were observed in Intensive Care Unit (ICU) length of stay (LOS), total LOS, and Marshall MOD score between PF and non-PF groups, respectively. Acid–base markers such as pH, lactate, LDH, and base deficit were all significantly altered in PF compared to non-PF cohort upon admission. Moreover, our analysis showed significant differences in inflammatory biomarkers (Prolactin, CRP, and IL-6), and clinical parameters (CPK, Hgb, Platelets count, and WBC) over the 7-day clinical course in patients with PF when compared to non-PF cohort. Conclusion In this matched cohort, patients with pelvic fractures exhibited biochemical and physiological alterations upon admission. Furthermore, our results suggest that pelvic fracture affects the clinical outcomes in severely injured patients, independently of injury severity, mechanism of injury, age or gender.
- 1 December 2016
- Published by Elsevier in Journal of Critical Care
- Vol. 36, 146-153
Individual-specific principal component analysis of circulating inflammatory mediators predicts early organ dysfunction in trauma patients
- 1 December 2016
- Published by Elsevier in Journal of Critical Care
- Vol. 36, 146-153
Individual-specific principal component analysis of circulating inflammatory mediators predicts early organ dysfunction in trauma patients
- Open Access
- 15 November 2016
- Published by Wiley in Mediators of Inflammation
- Vol. 2016, 1-13
Elevated Admission Base Deficit Is Associated with a Complex Dynamic Network of Systemic Inflammation Which Drives Clinical Trajectories in Blunt Trauma Patients
We hypothesized that elevated base deficit (BD) ≥ 4 mEq/L upon admission could be associated with an altered inflammatory response, which in turn may impact differential clinical trajectories. Using clinical and biobank data from 472 blunt trauma survivors, 154 patients were identified after excluding patients who received prehospital IV fluids or had alcohol intoxication. From this subcohort, 84 patients had a BD ≥ 4 mEq/L and 70 patients with BD < 4 mEq/L. Three samples within the first 24 h were obtained from all patients and then daily up to day 7 after injury. Twenty-two cytokines and chemokines were assayed using Luminex™ and were analyzed using two-way ANOVA and dynamic network analysis (DyNA). Multiple mediators of the innate and lymphoid immune responses in the BD ≥ 4 group were elevated differentially upon admission and up to 16 h after injury. DyNA revealed a higher, sustained degree of interconnectivity of the inflammatory response in the BD ≥ 4 patients during the initial 16 h after injury. These results suggest that elevated admission BD is associated with differential immune/inflammatory pathways, which subsequently could predispose patients to follow a complicated clinical course.
- 15 November 2016
- Published by Wiley in Mediators of Inflammation
- Vol. 2016, 1-13
Open AccessElevated Admission Base Deficit Is Associated with a Complex Dynamic Network of Systemic Inflammation Which Drives Clinical Trajectories in Blunt Trauma Patients
We hypothesized that elevated base deficit (BD) ≥ 4 mEq/L upon admission could be associated with an altered inflammatory response, which in turn may impact differential clinical trajectories. Using clinical and biobank data from 472 blunt trauma survivors, 154 patients were identified after excluding patients who received prehospital IV fluids or had alcohol intoxication. From this subcohort, 84 patients had a BD ≥ 4 mEq/L and 70 patients with BD < 4 mEq/L. Three samples within the first 24 h were obtained from all patients and then daily up to day 7 after injury. Twenty-two cytokines and chemokines were assayed using Luminex™ and were analyzed using two-way ANOVA and dynamic network analysis (DyNA). Multiple mediators of the innate and lymphoid immune responses in the BD ≥ 4 group were elevated differentially upon admission and up to 16 h after injury. DyNA revealed a higher, sustained degree of interconnectivity of the inflammatory response in the BD ≥ 4 patients during the initial 16 h after injury. These results suggest that elevated admission BD is associated with differential immune/inflammatory pathways, which subsequently could predispose patients to follow a complicated clinical course.
- 1 January 2016
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 263 (1) , 191-198
Temporal Patterns of Circulating Inflammation Biomarker Networks Differentiate Susceptibility to Nosocomial Infection Following Blunt Trauma in Humans
Background: Severe traumatic injury can lead to immune dysfunction that renders trauma patients susceptible to nosocomial infections (NI) and prolonged intensive care unit (ICU) stays. We hypothesized that early circulating biomarker patterns following trauma would correlate with sustained immune dysregulation associated with NI and remote organ failure. Methods: In a cohort of 472 blunt trauma survivors studied over an 8-year period, 127 patients (27%) were diagnosed with NI versus 345 trauma patients without NI. To perform a pairwise, case-control study with 1:1 matching, 44 of the NI patients were compared with 44 no-NI trauma patients selected by matching patient demographics and injury characteristics. Plasma obtained upon admission and over time were assayed for 26 inflammatory mediators and analyzed for the presence of dynamic networks. Results: Significant differences in ICU length of stay (LOS), hospital LOS, and days on mechanical ventilation were observed in the NI patients versus no-NI patients. Although NI was not detected until day 7, multiple mediators were significantly elevated within the first 24 hours in patients who developed NI. Circulating inflammation biomarkers exhibited 4 distinct dynamic patterns, of which 2 clearly distinguish patients destined to develop NI from those who did not. Mediator network connectivity analysis revealed a higher, coordinated degree of activation of both innate and lymphoid pathways in the NI patients over the initial 24 hours. Conclusions: These studies implicate unique dynamic immune responses, reflected in circulating biomarkers that differentiate patients prone to persistent critical illness and infections following injury, independent of mechanism of injury, injury severity, age, or sex.
- 1 January 2016
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 263 (1) , 191-198
Temporal Patterns of Circulating Inflammation Biomarker Networks Differentiate Susceptibility to Nosocomial Infection Following Blunt Trauma in Humans
Background: Severe traumatic injury can lead to immune dysfunction that renders trauma patients susceptible to nosocomial infections (NI) and prolonged intensive care unit (ICU) stays. We hypothesized that early circulating biomarker patterns following trauma would correlate with sustained immune dysregulation associated with NI and remote organ failure. Methods: In a cohort of 472 blunt trauma survivors studied over an 8-year period, 127 patients (27%) were diagnosed with NI versus 345 trauma patients without NI. To perform a pairwise, case-control study with 1:1 matching, 44 of the NI patients were compared with 44 no-NI trauma patients selected by matching patient demographics and injury characteristics. Plasma obtained upon admission and over time were assayed for 26 inflammatory mediators and analyzed for the presence of dynamic networks. Results: Significant differences in ICU length of stay (LOS), hospital LOS, and days on mechanical ventilation were observed in the NI patients versus no-NI patients. Although NI was not detected until day 7, multiple mediators were significantly elevated within the first 24 hours in patients who developed NI. Circulating inflammation biomarkers exhibited 4 distinct dynamic patterns, of which 2 clearly distinguish patients destined to develop NI from those who did not. Mediator network connectivity analysis revealed a higher, coordinated degree of activation of both innate and lymphoid pathways in the NI patients over the initial 24 hours. Conclusions: These studies implicate unique dynamic immune responses, reflected in circulating biomarkers that differentiate patients prone to persistent critical illness and infections following injury, independent of mechanism of injury, injury severity, age, or sex.
- 10 December 2015
- Published by SAGE Publications in Antioxidants & Redox Signaling
- Vol. 23 (17) , 1370-1387
Insights into the Role of Chemokines, Damage-Associated Molecular Patterns, and Lymphocyte-Derived Mediators from Computational Models of Trauma-Induced Inflammation
Significance: Traumatic injury elicits a complex, dynamic, multi-dimensional inflammatory response that is intertwined with complications such as multiple organ dysfunction and nosocomial infection. The complex interplay between inflammation and physiology in critical illness remains a challenge for translational research, including the extrapolation to human disease from animal models. Recent Advances: Over the past decade, we and others have attempted to decipher the bio-complexity of inflammation in these settings of acute illness, using computational models to improve clinical translation. In silico modeling has been suggested as a computationally-based framework for integrating data derived from basic biology experiments as well as preclinical and clinical studies. Critical Issues: Extensive studies in cells, mice, and human blunt trauma patients have led us to suggest: 1) that while an adequate level of inflammation is required for healing post-trauma, inflammation can be harmful when it becomes self-sustaining via a Damage-Associated Molecular Pattern (DAMP) / Toll-Like Receptor (TLR)-driven, feed-forward circuit; 2) that chemokines play a central regulatory role in driving either self-resolving or self-maintaining inflammation that drives the early activation of both classical innate and more recently-recognized lymphoid pathways; and 3) the presence of multiple thresholds and feedback loops which could significantly affect the propagation of inflammation across multiple body compartments. Future Directions: These insights from data-driven models into the primary drivers and interconnected networks of inflammation have been used to generate mechanistic computational models. Together, these models may be used to gain basic insights as well as serving to help define novel biomarkers and therapeutic targets.
- 10 December 2015
- Published by SAGE Publications in Antioxidants & Redox Signaling
- Vol. 23 (17) , 1370-1387
Insights into the Role of Chemokines, Damage-Associated Molecular Patterns, and Lymphocyte-Derived Mediators from Computational Models of Trauma-Induced Inflammation
Significance: Traumatic injury elicits a complex, dynamic, multi-dimensional inflammatory response that is intertwined with complications such as multiple organ dysfunction and nosocomial infection. The complex interplay between inflammation and physiology in critical illness remains a challenge for translational research, including the extrapolation to human disease from animal models. Recent Advances: Over the past decade, we and others have attempted to decipher the bio-complexity of inflammation in these settings of acute illness, using computational models to improve clinical translation. In silico modeling has been suggested as a computationally-based framework for integrating data derived from basic biology experiments as well as preclinical and clinical studies. Critical Issues: Extensive studies in cells, mice, and human blunt trauma patients have led us to suggest: 1) that while an adequate level of inflammation is required for healing post-trauma, inflammation can be harmful when it becomes self-sustaining via a Damage-Associated Molecular Pattern (DAMP) / Toll-Like Receptor (TLR)-driven, feed-forward circuit; 2) that chemokines play a central regulatory role in driving either self-resolving or self-maintaining inflammation that drives the early activation of both classical innate and more recently-recognized lymphoid pathways; and 3) the presence of multiple thresholds and feedback loops which could significantly affect the propagation of inflammation across multiple body compartments. Future Directions: These insights from data-driven models into the primary drivers and interconnected networks of inflammation have been used to generate mechanistic computational models. Together, these models may be used to gain basic insights as well as serving to help define novel biomarkers and therapeutic targets.
- 1 August 2015
- Published by Wolters Kluwer Health in Shock
- Vol. 44 (2) , 101-109
Impact of Injury Severity on Dynamic Inflammation Networks Following Blunt Trauma
Introduction: Clinical outcomes following trauma depend on the extent of injury and the host’s response to injury, along with medical care. We hypothesized that dynamic networks of systemic inflammation manifest differently as a function of injury severity in human blunt trauma. Study Design: From a cohort of 472 blunt trauma survivors studied following institutional review board approval, three Injury Severity Score (ISS) subcohorts were derived after matching for age and sex: mild ISS (49 patients [33 males and 16 females, aged 42 ± 1.9 years; ISS 9.5 ± 0.4]); moderate ISS (49 patients [33 males and 16 females, aged 42 ± 1.9; ISS 19.9 ± 0.4]), and severe ISS (49 patients [33 males and 16 females, aged 42 ± 2.5 years; ISS 33 ± 1.1]). Multiple inflammatory mediators were assessed in serial blood samples. Dynamic Bayesian Network inference was utilized to infer causal relationships based on probabilistic measures. Results: Intensive care unit length of stay, total length of stay, days on mechanical ventilation, Marshall Multiple Organ Dysfunction score, prevalence of prehospital hypotension and nosocomial infection, and admission lactate and base deficit were elevated as a function of ISS. Multiple circulating inflammatory mediators were significantly elevated in severe ISS versus moderate or mild ISS over both the first 24 h and out to 7 days after injury. Dynamic Bayesian Network suggested that interleukin 6 production in severe ISS was affected by monocyte chemotactic protein 1/CCL2, monokine inducible by interferon γ (MIG)/CXCL9, and IP-10/CXCL10; by monocyte chemotactic protein 1/CCL2 and MIG/CXCL9 in moderate ISS; and by MIG/CXCL9 alone in mild ISS over 7 days after injury. Conclusions: Injury Severity Score correlates linearly with morbidity, prevalence of infection, and early systemic inflammatory connectivity of chemokines to interleukin 6.
- 1 August 2015
- Published by Wolters Kluwer Health in Shock
- Vol. 44 (2) , 101-109
Impact of Injury Severity on Dynamic Inflammation Networks Following Blunt Trauma
Introduction: Clinical outcomes following trauma depend on the extent of injury and the host’s response to injury, along with medical care. We hypothesized that dynamic networks of systemic inflammation manifest differently as a function of injury severity in human blunt trauma. Study Design: From a cohort of 472 blunt trauma survivors studied following institutional review board approval, three Injury Severity Score (ISS) subcohorts were derived after matching for age and sex: mild ISS (49 patients [33 males and 16 females, aged 42 ± 1.9 years; ISS 9.5 ± 0.4]); moderate ISS (49 patients [33 males and 16 females, aged 42 ± 1.9; ISS 19.9 ± 0.4]), and severe ISS (49 patients [33 males and 16 females, aged 42 ± 2.5 years; ISS 33 ± 1.1]). Multiple inflammatory mediators were assessed in serial blood samples. Dynamic Bayesian Network inference was utilized to infer causal relationships based on probabilistic measures. Results: Intensive care unit length of stay, total length of stay, days on mechanical ventilation, Marshall Multiple Organ Dysfunction score, prevalence of prehospital hypotension and nosocomial infection, and admission lactate and base deficit were elevated as a function of ISS. Multiple circulating inflammatory mediators were significantly elevated in severe ISS versus moderate or mild ISS over both the first 24 h and out to 7 days after injury. Dynamic Bayesian Network suggested that interleukin 6 production in severe ISS was affected by monocyte chemotactic protein 1/CCL2, monokine inducible by interferon γ (MIG)/CXCL9, and IP-10/CXCL10; by monocyte chemotactic protein 1/CCL2 and MIG/CXCL9 in moderate ISS; and by MIG/CXCL9 alone in mild ISS over 7 days after injury. Conclusions: Injury Severity Score correlates linearly with morbidity, prevalence of infection, and early systemic inflammatory connectivity of chemokines to interleukin 6.